MRI基于2023版国际妇产科联盟分期评估子宫内膜癌进展
Progresses of MRI evaluating endometrial cancer based on 2023 International Federation of Gynecology and Obstetrics staging
刘晓怡 1王珂 1苟心怡 1王屹 1洪楠 1程瑾1
作者信息
- 1. 北京大学人民医院放射科,北京 100044
- 折叠
摘要
子宫内膜癌(EC)是常见妇科恶性肿瘤;MRI对EC评估具有重要价值.2023年国际妇产科联盟(FIGO)分期做出重大修订,以更细致地对EC进行风险分层,也使MRI面临新的挑战.本文就MRI基于2023版FIGO分期评估EC进展进行综述.
Abstract
Endometrial cancer(EC)is a common gynecological malignancy.MRI plays an important role for evaluation of EC.In 2023,International Federation of Gynecology and Obstetrics(FIGO)staging was significantly modified to perform more detailed risk stratification of EC,which brought new challenges to MRI.The progresses of MRI for evaluating EC based on 2023 FIGO staging were reviewed in this article.
关键词
子宫内膜肿瘤/肿瘤分期/磁共振成像Key words
endometrial neoplasms/neoplasm staging/magnetic resonance imaging引用本文复制引用
出版年
2024
NETL
NSTL
万方数据